Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell Hematologic Malignancies

Clinical trial NCT06037018 · RECRUITING

Trial details

NCT number: NCT06037018
Sponsor: CytoCares Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-hodgkin Lymphoma Acute Lymphoblastic Leukaemia Chronic Lymphocytic Leukemia

Start date: 2023-08-07
Primary completion: 2026-03-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.